Huntingdon and Harlan Laboratories to Become Envigo
PTSM: Pharmaceutical Technology Sourcing and Management
The combined company has been created through the integration of Huntingdon Life Sciences and Harlan Laboratories announces a new company name.
Huntingdon Life Sciences (HLS) and Harlan Laboratories have announced that the combined companies will be called Envigo (pronounced En-vee-go). The new name will be launched later in 2015.
According to a company statement, the letters “E” and “N” come from “enhance, enrich and enable.” “VIGO” originates in “vigorous and invigorate”, and the Latin word “vita” meaning “life.”
The combined organization has 3800 employees and sales approaching $500 million.
Source: Huntingdon Life Sciences
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
